ResearcherMedical College of WisconsinNo recent work listed

Gang Cheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7170-8968; OpenAlex author ID A5053435940. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper

Papers 2

Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells. Co-author DOI 10.1158/0008-5472.can-15-2534 ↗
Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation. Co-author DOI 10.1038/bjc.2014.272 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Balaraman Kalyanaraman · 2 shared papers, 2014–2016 · strength 0.10
- Paper Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancrea… DOI 10.1158/0008-5472.can-15-2534 ↗
- Paper Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation. DOI 10.1038/bjc.2014.272 ↗
Michael B. Dwinell · 2 shared papers, 2014–2016 · strength 0.10
- Paper Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancrea… DOI 10.1158/0008-5472.can-15-2534 ↗
- Paper Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation. DOI 10.1038/bjc.2014.272 ↗
Susan Tsai · 1 shared paper, 2014 · strength 0.05
- Paper Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation. DOI 10.1038/bjc.2014.272 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.